David Gisselsson

David Gisselsson

Lunds Universitet

H-index: 50

Europe-Sweden

About David Gisselsson

David Gisselsson, With an exceptional h-index of 50 and a recent h-index of 28 (since 2020), a distinguished researcher at Lunds Universitet, specializes in the field of cancer, genetics, pathology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Hallmark discoveries in the biology of Wilms tumour

Abstract PR003: Multi-drug adaptive therapy protocol in vitro: An exercise in optimization for neuroblastoma

Abstract B001: Elucidating metastatic pathways in pediatric cancers

Weaponized genomics: potential threats to international and human security

Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors—a nationwide, prospective Swedish study

A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage

Current and emerging sequencing-based tools for precision cancer medicine

Tumor biology, biomarkers, and liquid biopsy in pediatric renal tumors

David Gisselsson Information

University

Position

Professor of Molecular Pathology

Citations(all)

7905

Citations(since 2020)

2302

Cited By

6487

hIndex(all)

50

hIndex(since 2020)

28

i10Index(all)

113

i10Index(since 2020)

63

Email

University Profile Page

Lunds Universitet

Google Scholar

View Google Scholar Profile

David Gisselsson Skills & Research Interests

cancer

genetics

pathology

Top articles of David Gisselsson

Title

Journal

Author(s)

Publication Date

Hallmark discoveries in the biology of Wilms tumour

Daniela Perotti

Richard D Williams

Jenny Wegert

Jack Brzezinski

Mariana Maschietto

...

2024/3

Abstract PR003: Multi-drug adaptive therapy protocol in vitro: An exercise in optimization for neuroblastoma

Cancer Research

Subhayan Chattopadhyay

Jenny Karlsson

David Gisselsson

2024/2/1

Abstract B001: Elucidating metastatic pathways in pediatric cancers

Cancer Research

Natalie Andersson

Michele Ferro

Caroline Jansson

Jenny Karlsson

Linda Holmquist Mengelbier

...

2024/2/1

Weaponized genomics: potential threats to international and human security

Subhayan Chattopadhyay

Tony Ingesson

Alberto Rinaldi

Oscar Larsson

JJ Widen

...

2024/1

Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors—a nationwide, prospective Swedish study

The Lancet Regional Health–Europe

Bianca Tesi

Kristina Lagerstedt Robinson

Frida Abel

Teresita Díaz de Ståhl

Sara Orrsjö

...

2024/4/1

A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage

Modern Pathology

Kaname Uno

Bahar Rastegar

Caroline Jansson

Geoffroy Durand

Anders Valind

...

2024/1/1

Current and emerging sequencing-based tools for precision cancer medicine

Anders Edsjö

David Gisselsson

Johan Staaf

Louise Holmquist

Thoas Fioretos

...

2024/4/1

Tumor biology, biomarkers, and liquid biopsy in pediatric renal tumors

Amy L Walz

Mariana Maschietto

Brian Crompton

Nicholas Evageliou

David Dix

...

2023/5

SIX1 as a Novel Immunohistochemical Marker in the Differential Diagnosis of Rhabdomyosarcoma

Fetal and Pediatric Pathology

Daniel Ehinger

Hanna Frostberg

Sofia Larsson

David Gisselsson

2023/9/3

Modelling evolution at the boundaries of solid tumours

Nature Ecology & Evolution

Subhayan Chattopadhyay

David Gisselsson

2023/4

Resolving the pathogenesis of anaplastic Wilms tumors through spatial mapping of cancer cell evolution

Clinical Cancer Research

Bahar Rastegar

Natalie Andersson

Alexandra Petersson

Jenny Karlsson

Subhayan Chattopadhyay

...

2023/7/14

Inactivation of RB1, CDKN2A, and TP53 have distinct effects on genomic stability at side‐by‐side comparison in karyotypically normal cells

Genes, Chromosomes and Cancer

Natalie Andersson

Karim H Saba

Linda Magnusson

Jenny Nilsson

Jenny Karlsson

...

2023/2

Wargaming cancer: a strategy for future precision oncology?

Tony Ingesson

David Gisselsson

2023/7/1

Building a precision medicine infrastructure at a national level: The Swedish experience

Anders Edsjö

Anna Lindstrand

David Gisselsson

Paula Mölling

Mikaela Friedman

...

2023/1

Diagnostic yield from a nationwide implementation of precision medicine for all children with cancer

JCO Precision Oncology

Elisabeth Wadensten

Sandra Wessman

Frida Abel

Teresita Diaz De Ståhl

Bianca Tesi

...

2023/6

Systematic orientation of fresh rectal suction biopsies improves histopathological diagnostics in hirschsprung’s disease–a method description and preliminary report

BMC pediatrics

Emma Fransson

Emilia Gottberg

Rodrigo Munoz Mitev

David Gisselsson

Kristine Hagelsteen

...

2023/5/17

Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy

Oncoimmunology

Anders Valind

Bronte Manouk Verhoeven

Jens Enoksson

Jenny Karlsson

Gustav Christensson

...

2023/12/31

Delineating the intra-patient heterogeneity of molecular alterations in treatment-naïve colorectal cancer with peritoneal carcinomatosis

Modern Pathology

Christina Siesing

Alexandra Petersson

Thora Ulfarsdottir

Subhayan Chattopadhyay

Björn Nodin

...

2022/7

Abstract A021: On-treatment ctDNA monitoring of pancreatic cancer holds promise for improved treatment stratification

Cancer Research

Alexandra Petersson

Sofie Olsson Hau

Jakob Eberhard

Markus Heidenblad

David Gisselsson

...

2022/5/15

Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance

Science Advances

Adriana Mañas

Kristina Aaltonen

Natalie Andersson

Karin Hansson

Aleksandra Adamska

...

2022/10/28

See List of Professors in David Gisselsson University(Lunds Universitet)